Viral Hepatitis
📧 Sign up to get email alerts when something new happens for Viral Hepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-07-20Clinical Trial Update: Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention [NA]
This trial compares web-based versus traditional adolescent HIV prevention approaches. The current status of the study is unknown.
-
FDA approval · 2011-05-27FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)
FDA approved a supplemental application for PEGASYS (peginterferon alfa-2a) submitted by pharmaand GmbH.
-
FDA approval · 2011-05-09FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)
FDA approved a supplemental application for PEGASYS (peginterferon alfa-2a) filed by pharmaand GmbH.
-
FDA approval · 2011-03-16FDA Approved: RIBAVIRIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ribavirin by Aurobindo Pharma Limited (ANDA 079111).
-
FDA approval · 2011-02-23FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)
FDA approved a supplemental application for PEGASYS (peginterferon alfa-2a) filed by pharmaand GmbH.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2010-05-24FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)
FDA approved a supplemental application for PEGASYS (peginterferon alfa-2a) submitted by pharmaand GmbH, associated with a labeling update o…
-
FDA approval · 2010-03-24FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) from Gilead Sciences, Inc.
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Effect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972. [Phase 2]
A Phase 2 study evaluated how chronic viral hepatitis affects the pharmacokinetics of NRL972; the trial has completed.
-
FDA approval · 2009-11-10FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) submitted by Gilead Sciences, Inc. This action update…
-
CLINICAL_TRIALS trial_result · 2009-11-10Clinical Trial Update: Anti-tuberculosis (TB) Drug Levels and Hepatotoxicity
Completed clinical trial update examining anti-tuberculosis drug levels and associated hepatotoxicity; data relate to hepatitis and tubercul…
-
FDA approval · 2009-09-17FDA Approved: RIBAVIRIN — Original Application (Aurobindo Pharma Limited)
FDA approved Ribavirin as an Original Application (ANDA) from Aurobindo Pharma Limited, authorizing a generic ribavirin product.
-
FDA approval · 2009-08-07FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)
FDA approved a supplemental application for PEGASYS (peginterferon alfa-2a) from pharmaand GmbH.
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity [NA]
A completed clinical trial evaluated the effect of N-acetylcysteine in preventing or mitigating liver toxicity caused by anti-tuberculosis d…
-
FDA approval · 2009-04-20FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)
FDA approved a supplemental application for PEGASYS (pegylated interferon alfa-2a) submitted by pharmaand GmbH.
-
CLINICAL_TRIALS research · 2009-02-12Clinical Trial Update: Evaluation and Medico-Economic Study of FIBROSCAN in Patients With Viral Hepatitis
A terminated clinical trial evaluating FibroScan for viral hepatitis and its medico-economic assessment has been reported.
-
FDA approval · 2008-11-04FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) submitted by Gilead Sciences, indicating changes to i…
-
FDA approval · 2008-08-11FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) by Gilead Sciences, Inc., updating the product's labe…
-
FDA approval · 2008-06-13FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)
FDA approves a supplemental application for PEGASYS (peginterferon alfa-2a) submitted by pharmaand GmbH.
-
CLINICAL_TRIALS research · 2008-06-03Clinical Trial Update: Acute Viral Hepatitis and Diabetes Mellitus
Clinical trial update involving acute viral hepatitis and diabetes mellitus; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2008-05-19Clinical Trial Update: Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease
A completed clinical trial evaluated the effects of growth factors IGF-1, IGFBP-3, and growth hormone (somatropin) in patients with chronic …
-
FDA approval · 2008-05-16FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Viread (tenofovir disoproxil fumarate) from Gilead Sciences, Inc. The approval updates the p…
-
FDA label_change · 2008-04-04FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Emtriva (emtricitabine) to update its labeling, reflecting changes approved for the product.
-
EMA safety_alert · 2008-02-14Public statement: Risk of peripheral neuropathy with Sebivo (telbivudine)
EMA public statement warning about risk of peripheral neuropathy associated with Sebivo (telbivudine).
-
FDA approval · 2008-02-01FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Epivir (lamivudine) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2008-01-17Clinical Trial Update: Sedation and Analgesia for Transjugular Liver Biopsy: A Randomized Double Blind Placebo Controlled Trial [Phase 4]
Phase 4 randomized double-blind placebo-controlled trial evaluating sedation and analgesia during transjugular liver biopsy in patients with…